Menu +

Tag: acute

Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020

• Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive adult leukaemia live longer compared to azacitidine alone • Data will be presented as a late-breaking abstract at the 25th European Hematology Association Virtual Congress Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the […]